A multicenter, open-label, randomized, parallel groups study to assess the long-term safety performance of fexofenadine compared to montelukast in subjects with asthma

Trial Profile

A multicenter, open-label, randomized, parallel groups study to assess the long-term safety performance of fexofenadine compared to montelukast in subjects with asthma

Completed
Phase of Trial: Phase III

Latest Information Update: 19 Aug 2008

At a glance

  • Drugs Fexofenadine; Montelukast
  • Indications Asthma
  • Focus Adverse reactions
  • Sponsors Aventis Pharmaceuticals
  • Most Recent Events

    • 14 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top